Fuso Pharmaceutical Industries Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fuso Pharmaceutical Industries Ltd with three other
companies in this sector in Japan:
Katakura Industries Co Ltd
sales of 44.31 billion Japanese Yen [US$395.67 million]
of which 32%
was Pharmaceutical Products),
Aska Pharmaceutical Company Limited
(48.94 billion Japanese Yen [US$437.07 million]
of which 90%
was Pharmaceutical Products Business), and
Nippon Chemiphar Co., Ltd.
(35.33 billion Japanese Yen [US$315.51 million]
of which 97%
was Pharmaceutical Business).
During the year ended March of 2018, sales at
Fuso Pharmaceutical Industries Ltd were ¥45.90 billion (US$409.89 million).
decrease of 1.9%
versus 2017, when the company's sales were ¥46.78 billion.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Fuso Pharmaceutical Industries Ltd had sales
of ¥48.61 billion.
Contributing to the drop in overall sales was the 1.9% decline
in Pharmaceutical Business, from ¥46.61 billion to ¥45.73 billion.
However, these declines were partially offset by the increase in sales of
Real Estate Business (up 1.2% to ¥170.00 million)